These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23777691)

  • 21. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
    Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
    J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.
    Suwantika AA; Tu HA; Postma MJ
    Vaccine; 2013 Jul; 31(32):3300-7. PubMed ID: 23707163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries.
    de Oliveira LH; Danovaro-Holliday MC; Andrus JK; de Fillipis AM; Gentsch J; Matus CR; Widdowson MA;
    J Infect Dis; 2009 Nov; 200 Suppl 1():S131-9. PubMed ID: 19821710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods and challenges for the health impact assessment of vaccination programs in Latin America.
    Sartori AM; Nascimento Ade F; Yuba TY; Soárez PC; Novaes HM
    Rev Saude Publica; 2015; 49():. PubMed ID: 26759964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.
    Lamberti LM; Ashraf S; Walker CL; Black RE
    Pediatr Infect Dis J; 2016 Sep; 35(9):992-8. PubMed ID: 27254030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines.
    Kane EM; Turcios RM; Arvay ML; Garcia S; Bresee JS; Glass RI
    Rev Panam Salud Publica; 2004 Dec; 16(6):371-7. PubMed ID: 15673479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
    Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
    Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.
    Ngabo F; Mvundura M; Gazley L; Gatera M; Rugambwa C; Kayonga E; Tuyishime Y; Niyibaho J; Mwenda JM; Donnen P; Lepage P; Binagwaho A; Atherly D
    PLoS One; 2016; 11(2):e0149805. PubMed ID: 26901113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective.
    Granados-García V; Velázquez-Castillo R; Garduño-Espinosa J; Torres-López J; Muñoz-Hernández O
    Rev Invest Clin; 2009; 61(1):18-25. PubMed ID: 19507471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.